These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 29479888)

  • 1. Decreased Serum Level of miR-155 is Associated with Obesity and its Related Metabolic Traits.
    Mahdavi R; Ghorbani S; Alipoor B; Panahi G; Khodabandehloo H; Esfahani EN; Razi F; Meshkani R
    Clin Lab; 2018 Jan; 64(1):77-84. PubMed ID: 29479888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased serum microRNA-21 level is associated with obesity in healthy and type 2 diabetic subjects.
    Ghorbani S; Mahdavi R; Alipoor B; Panahi G; Nasli Esfahani E; Razi F; Taghikhani M; Meshkani R
    Arch Physiol Biochem; 2018 Oct; 124(4):300-305. PubMed ID: 29113498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum circulating microRNA profiling for identification of potential type 2 diabetes and obesity biomarkers.
    Pescador N; Pérez-Barba M; Ibarra JM; Corbatón A; Martínez-Larrad MT; Serrano-Ríos M
    PLoS One; 2013; 8(10):e77251. PubMed ID: 24204780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression of microRNA-21 is associated with increased cytokine production in peripheral blood mononuclear cells (PBMCs) of obese type 2 diabetic and non-diabetic subjects.
    Mazloom H; Alizadeh S; Esfahani EN; Razi F; Meshkani R
    Mol Cell Biochem; 2016 Aug; 419(1-2):11-7. PubMed ID: 27370645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating Soluble ACE2 and Upstream microRNA Expressions in Serum of Type 2 Diabetes Mellitus Patients.
    Elemam NM; Hasswan H; Aljaibeji H; Sulaiman N
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34067683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma level of miR-93 is associated with higher risk to develop type 2 diabetic retinopathy.
    Zou HL; Wang Y; Gang Q; Zhang Y; Sun Y
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1159-1166. PubMed ID: 28382439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiling peripheral microRNAs in obesity and type 2 diabetes mellitus.
    Wu L; Dai X; Zhan J; Zhang Y; Zhang H; Zhang H; Zeng S; Xi W
    APMIS; 2015 Jul; 123(7):580-5. PubMed ID: 25912229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulated microRNA-155 expression in peripheral blood mononuclear cells of type 2 diabetic patients is not correlated with increased inflammatory cytokine production.
    Mazloom H; Alizadeh S; Pasalar P; Esfahani EN; Meshkani R
    Cytokine; 2015 Dec; 76(2):403-408. PubMed ID: 26188366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Circulating MicroRNAs and Myokines and Interactions with Serum Osteopontin in Type 2 Diabetic Patients with Moderate and Poor Glycemic Control: A Biochemical and Molecular Study.
    Al-Rawaf HA; Alghadir AH; Gabr SA
    Biomed Res Int; 2021; 2021():7453000. PubMed ID: 34917685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered levels of circulating cytokines and microRNAs in lean and obese individuals with prediabetes and type 2 diabetes.
    Nunez Lopez YO; Garufi G; Seyhan AA
    Mol Biosyst; 2016 Dec; 13(1):106-121. PubMed ID: 27869909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum microRNA-33 levels in pre-diabetic and diabetic patients.
    Shahouzehi B; Eghbalian M; Fallah H; Aminizadeh S; Masoumi-Ardakani Y
    Mol Biol Rep; 2021 May; 48(5):4121-4128. PubMed ID: 34146198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating miR-146a, miR-34a and miR-375 in type 2 diabetes patients, pre-diabetic and normal-glycaemic individuals in relation to β-cell function, insulin resistance and metabolic parameters.
    García-Jacobo RE; Uresti-Rivera EE; Portales-Pérez DP; González-Amaro R; Lara-Ramírez EE; Enciso-Moreno JA; García-Hernández MH
    Clin Exp Pharmacol Physiol; 2019 Dec; 46(12):1092-1100. PubMed ID: 31355469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased serum level of miR-146a as sign of chronic inflammation in type 2 diabetic patients.
    Baldeón R L; Weigelt K; de Wit H; Ozcan B; van Oudenaren A; Sempértegui F; Sijbrands E; Grosse L; Freire W; Drexhage HA; Leenen PJ
    PLoS One; 2014; 9(12):e115209. PubMed ID: 25500583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating microRNAs in obese and lean heart failure patients: A case-control study with computational target prediction analysis.
    Thomé JG; Mendoza MR; Cheuiche AV; La Porta VL; Silvello D; Dos Santos KG; Andrades ME; Clausell N; Rohde LE; Biolo A
    Gene; 2015 Dec; 574(1):1-10. PubMed ID: 26211628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma
    Jiang Q; Lyu XM; Yuan Y; Wang L
    Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28108673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the levels of circulating miR-29a, miR-122, sestrin 2 and inflammatory markers in obese children with/without type 2 diabetes: a case control study.
    Mohany KM; Al Rugaie O; Al-Wutayd O; Al-Nafeesah A
    BMC Endocr Disord; 2021 Aug; 21(1):152. PubMed ID: 34344352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between miR-103 and miR-133a Expression and the Circulating ANGPTL8 in Type 2 Diabetic Patients and Healthy Control Subjects.
    Ghasemi H; Karimi J; Khodadadi I; Tavilani H
    Clin Lab; 2019 Nov; 65(11):. PubMed ID: 31710446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating microRNA-223 as a potential biomarker for obesity.
    Wen D; Qiao P; Wang L
    Obes Res Clin Pract; 2015; 9(4):398-404. PubMed ID: 25842981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential.
    Nemecz M; Stefan DS; Comarița IK; Constantin A; Tanko G; Guja C; Georgescu A
    Cardiovasc Diabetol; 2023 Sep; 22(1):260. PubMed ID: 37749569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-483-5p associates with obesity and insulin resistance and independently associates with new onset diabetes mellitus and cardiovascular disease.
    Gallo W; Esguerra JLS; Eliasson L; Melander O
    PLoS One; 2018; 13(11):e0206974. PubMed ID: 30408096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.